Olympus Corporation of the Americas recalled 103,731 units of the ViziShot 2FLEX aspiration needle on August 6, 2025. The recall stems from a risk of undetected, deformed a-traumatic tips that could affect patient safety. The product is distributed worldwide, including the US, Australia, and Germany.
Potential for undetected, deformed a-traumatic tips.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Olympus Corporation of the Americas or your healthcare provider for instructions. Notification method: Letter
The recalled product is the ViziShot 2FLEX aspiration needle, model number NA-U403SX-4019. It consists of a handle, sheath, needle, and removable stylet. The device was sold globally between August 4, 2022, and April 25, 2025.
The device poses a high hazard risk due to the potential for undetected, deformed a-traumatic tips. This defect could lead to serious complications during medical procedures.
There are no specific reports of incidents or injuries associated with this recall. The recall follows a precautionary measure due to the potential risks identified.
Patients and healthcare providers should stop using the ViziShot 2FLEX immediately. Follow the recall instructions provided by Olympus and contact your healthcare provider for further guidance.
For more information, contact Olympus Corporation of the Americas or visit their website. Additional recall details are available at the FDA website.
Glenmark Pharmaceuticals Inc. recalled 13,824 tubes of Azelaic Acid Gel on September 17, 2025. The recall stems from market complaints regarding a gritty texture. Consumers should stop using the product immediately and contact their healthcare provider.
Skin MD by Dr Monika Kiripolsky recalled its Body Acne Cleanser on September 12, 2025. The recall follows the discovery of elevated benzene levels in the product. This contamination poses a high health risk to consumers in California and Georgia.
Private Label Skin Care recalled its Micronized BPO Gel Cleanser 10% on September 12, 2025. Elevated benzene levels prompted the recall in California and Georgia. Consumers must stop using the product immediately and seek guidance from healthcare providers.